By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Next Pharmaceuticals 

Four Venture, Suite 200

Irvine  California  92618  U.S.A.
Phone: 949-450-0203 Fax: 949-450-0163




Company News
Next Pharmaceuticals Begins Sale Of Sytrinol® Product 1/10/2014 9:11:58 AM
Health Canada Approves Next Pharmaceuticals' Relora® 4/2/2013 7:08:37 AM
Next Pharmaceuticals Completes Sale of U.S. Affiliate 11/29/2012 12:24:35 PM
Next Pharmaceuticals Announces Vity Awards 2008 Include Next Pharmaceuticals's Relora® and Seditol® 7/14/2008 11:12:15 AM
Published Study Reveals Next Pharmaceuticals' Flavoxine(TM) Reduces Multiple Heart Health Risk Factors Including High Cholesterol 6/19/2008 11:09:57 AM
Next Pharmaceuticals Announces a New Clinical Study Demonstrating Relora(R) Significantly Relieves Short-Term Anxiety in Healthy Women 5/8/2008 9:54:17 AM
Next Pharmaceuticals Discloses Results of Nexrutine(R) Clinical Study 11/29/2007 10:17:54 AM
Next Pharmaceuticals: Sleepless in Cincinnati Say Seditol® Promotes Restful Night's Sleep 10/22/2007 10:10:16 AM
Next Pharmaceuticals Welcomes Marilyn Barrett, Ph.D. 5/4/2007 3:14:49 AM
Next Pharmaceuticals Reveals Nexrutine(R) Prevents Prostate Cancer Progression in Pre-clinical Animal Model 5/2/2007 1:10:32 PM